Skip to Main

FDA Approves First New Drug for ALS in 22 Years

Americans suffering from Lou Gehrig’s disease will soon have a new drug available for treatment.

The FDA has approved the drug called Radicava.

Its maker says the drug can slow down the patient’s physical decline by 33 percent.

This is the first drug approved specifically for the condition in more than 20 years.   

Lou Gehrig’s disease, or ALS, is a degenerative disease affecting the ability to control muscle movements.

Up to 15,000 Americans suffer from it, and its cause in still unclear.

The new drug is expected to be on the market in August.